Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
BMRA

BIOMERICA (BMRA) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $1.84 -2.6% on the day -37.6% over 12 months 52-week range $1.49 – $3.20

Share price and insider trades

BMRA closeInsider buyInsider sale
1.001.502.002.503.003.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $50,000 on 2026-08-20 · M. Huff GaryBought $108,000 on 2026-08-26 · Allen Barbieri, David Moatazedi, Eric Chin, Zackary S. Irani
Bought, 12 months$158K
Sold, 12 months$0
Insiders buying5
Insiders selling0

BIOMERICA insider trading at a glance (Oct 9, 2026): in the past 12 months, 5 insiders bought $158K and 0 sold $0 of BMRA stock on the open market, including a cluster buy that began Aug 20, 2026.

BMRA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $158K bought (5 trades)$158KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$158K5—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$8.4MMedical Devices
Profit margin-84.8%Revenue growth +16.8%
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit+$24KOn all tracked purchases +15.0%

Summary

Over the past 12 months, 5 BIOMERICA INC insiders reported open-market purchases totaling $158K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Aug 20, 2026, when 5 insiders bought a combined $158K.

BMRA stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 27SEC M. Huff GaryDirector Buy 31,25051,250 held (+156%) $1.60 $50K +15.0% —
Aug 27SEC Zackary S. IraniCEO Buy 31,250242,570 held (+15%) $1.60 $50K +15.0% —
Aug 27SEC Allen BarbieriChair Buy 20,00073,542 held (+37%) $1.60 $32K +15.0% —
Aug 27SEC David MoatazediDirector Buy 10,00040,625 held (+33%) $1.60 $16K +15.0% —
Aug 27SEC Eric ChinDirector Buy 6,25038,750 held (+19%) $1.60 $10K +15.0% —

Insiders at BIOMERICA INC

InsiderBoughtSoldLast filingScore
M. Huff GaryDirector $50K — Aug 27, 2026 —
Zackary S. IraniCEO $50K — Aug 27, 2026 —
Allen BarbieriChair $32K — Aug 27, 2026 —
David MoatazediDirector $16K — Aug 27, 2026 —
Eric ChinDirector $10K — Aug 27, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

BMRA stock: common questions

Are BIOMERICA INC insiders buying BMRA stock?

In the past 12 months, 5 insiders reported open-market purchases of BMRA worth $158K. The latest was Director M. Huff Gary bought $50K of BMRA at $1.60 — first open-market purchase in our records; raises the stake by 156%.

Are BIOMERICA INC insiders selling BMRA stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BMRA's 52-week range?

Over the past year BMRA has traded between $1.49 and $3.20. It last closed at $1.84 on Oct 9, 2026.